CCR10 and its ligand CCL28 are known to participate in the recruitment of tumor TReg lymphocytes [13], and a decrease in CD4+ CCR10+ cells may reflect a reduced global presence of CCR10-expressing TRegs and, therefore, a reduced recruitment of these cells by the tumor. The gene discussed is CCR10; the disease is neoplasm.